| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.02B | +751.6% |
| R&D Expense | $110.0M | +235.3% |
| SG&A Expense | $2.99B | +556.6% |
| Operating Income | -$277.9M | -246.5% |
| Interest Expense | $90.4M | +58.0% |
| Pre-tax Income | -$1.93B | -928.3% |
| Income Tax | -$296.9M | -545.2% |
| Net Income | -$1.63B | -1081.6% |
| EPS (Basic) | -$6.28 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.82B | +158.5% |
| Short-term Investments | $623.0M | -36.0% |
| Accounts Receivable | $1.12B | +374.5% |
| Inventory | $665.2M | +438.1% |
| Current Assets | $4.89B | +130.2% |
| Total Assets | $57.11B | +821.3% |
| Current Liabilities | $8.02B | +1796.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.43B | +359.3% |
| Capital Expenditures | $3.10B | +851.5% |
| Investing Cash Flow | -$2.81B | -920.7% |
| Financing Cash Flow | -$277.1M | -233.5% |
| Free Cash Flow | -$668.3M | -428.0% |
| -399.0% |
| EPS (Diluted) | -$6.28 | -399.0% |
| Long-term Debt |
| $1.98B |
| +32.3% |
| Total Liabilities | $36.72B | +1312.4% |
| Stockholders' Equity | $19.88B | +467.6% |